PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Envista Holdings Corporation

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Envista Holdings Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 6.5 times. Higher than 90% of Healthcare companies in United States.
  • Growth Efficiency Ratio: Sales grew 6% in 3 years, but profit fell: $130 less profit per $100 of extra sales. Lower than 88% of Healthcare companies in United States.

Where $100 of sales goes

$91Operating costs$1.3Interest$1.7Net profit

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

6.5×

Over the last 3 years its own operating cash covered its investment spending (capex) 6.5 times.

Higher than 90% of Healthcare companies in United States.

Cash Locked Ratio

$17

For every $100 of sales, $17 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $16 tied up three years earlier.

Less money tied up than 65% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

1/3 · 1/3

Sales grew in 1 of the last 3 years; profit grew in 1 of 3.

Less steady than 70% of Healthcare companies in United States.

Growth Efficiency Ratio

−$130

Sales grew 6% in 3 years, but profit fell: $130 less profit per $100 of extra sales.

Lower than 88% of Healthcare companies in United States.

Asset Productivity Ratio

+6% / -14%

In 3 years sales changed by +6% while total assets changed by -14%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

7.1×

Debt due within a year is covered 7.1 times by its yearly operating cash.

Higher than 82% of Healthcare companies in United States.

Cash Cushion Ratio

−10%

Debt, after subtracting cash, equals 10% of its market value (net debt).

Lower than 79% of Healthcare companies in United States.

Tangible Assets Ratio

47%

Of every $100 the company owns, $47 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 83% of Healthcare companies in United States.

Tangible Net Worth Ratio

4%

Of every $100 of net worth, $4 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 71% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Envista Holdings Corporation owes $0.45 for every $1 it owns. Envista Holdings Corporation returned to profit in the year to Dec 2025, after a loss the year before.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

41.3

Investors pay $41.3 for every $1 of Envista Holdings Corporation's yearly profit, higher than 74% of Healthcare companies in United States.

P/B ratio

1.25

The share price is 1.25 times Envista Holdings Corporation's book value per share, lower than 74% of Healthcare companies in United States.

Market cap

$3.9 B

The total market value of all of Envista Holdings Corporation's shares at today's price (share price × number of shares), larger than 82% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$3.1 B

What Envista Holdings Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$19.15

Net worth divided by the number of shares. The share price of $23.97 is 1.3 times this, which is the P/B above.

Return on equity (ROE)

3.1%

Envista Holdings Corporation earned 3.1% on its shareholders' money over the last year, higher than 78% of Healthcare companies in United States.

Owes vs Owns

0.45×

Envista Holdings Corporation owes $0.45 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.

Dividend yield

None

Envista Holdings Corporation does not currently pay a dividend.

Revenue growth

+8%

Revenue rose 8% in the year to Dec 2025, and grew 2% a year on average over 3 years.

Profit growth

Back to profit

Envista Holdings Corporation returned to profit in the year to Dec 2025, after a loss the year before.

Profit margin

1.7%

Envista Holdings Corporation keeps $2 of every $100 of revenue as net profit.

Cash quality

5.9×

Cash from Envista Holdings Corporation's business was 5.9× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

6.4×

Envista Holdings Corporation's operating profit covered its interest costs 6.4 times in the year to Dec 2025.

Cash vs debt

Net debt

Envista Holdings Corporation had $386 M more debt than cash (net debt) at Dec 2025.

Questions

What is Envista Holdings Corporation's P/E ratio?

Investors pay $41.3 for every $1 of Envista Holdings Corporation's yearly profit, higher than 74% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Envista Holdings Corporation: $3.9 B ÷ $3.1 B (30 Jun 2026) = 1.3.

What is Envista Holdings Corporation's return on equity?

Envista Holdings Corporation earned 3.1% on its shareholders' money over the last year, higher than 78% of Healthcare companies in United States.

How much does Envista Holdings Corporation owe compared with what it owns?

Envista Holdings Corporation owes $0.45 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.

Does Envista Holdings Corporation pay a dividend?

No. Envista Holdings Corporation does not currently pay a dividend.

Is Envista Holdings Corporation's revenue growing?

Revenue rose 8% in the year to Dec 2025, and grew 2% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.